GLP Watchdog
Curve logo

Curve Review

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.6/10

Best for: knowing which pharmacy fills the vial — it names VialsRx

7.6
★★★★☆3.8/5

Curve's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.

$175/mo
Same price at every dose

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

Commit longer and pay less: semaglutide spans $99-$175/mo and tirzepatide $135-$225/mo, dose making no difference, and each tier absorbs expedited shipping at no cost, the drug, the prescription and the consultation, with membership charged to nobody. Try Curve LLC leans on providers from Beluga Health, licensed everywhere in the 50 states, and on a 503A compounder in the US, VialsRx. A questionnaire replaces the video visit, reviewed by a provider within 24 hours. HSA/FSA is welcome; insurance isn't accepted. LegitScript-certified.

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
GLP-1 from $175/moFlat across dosesIncludes medication + consultAll 50 statesPharmacy namedNo FDA letter on record

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

Vetted alternatives to Curve

7.9/ 10
Verified partner

Oak

Best for: semaglutide at $119/month, 37% under the register median

★★★★☆4/5

Editorial score · methodology

$119/mo
CompoundedSemaglutideTirzepatideGlutathioneNAD+LegitScript Verified
Get StartedRead full Oak review →
6.5/ 10
Verified partner

Direct Meds

Best for: compounded semaglutide at $249/month

★★★☆☆3.3/5

Editorial score · methodology

$249/mo
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript VerifiedFDA Warning
Get StartedRead full Direct Meds review →
8.8/ 10
Verified partner

Found

Best for: tirzepatide at $169/month, 37% under the register median

★★★★☆4.4/5

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatideOrforglipron
Get StartedRead full Found review →
Curve logo
3.8 / 5
Our editorial rating
Visit Curve →

from $175/mo · no insurance needed

Curve at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$175/mo (Month-to-month; drops to $145/mo (quarterly), $120/mo (6-month), or $99/mo on annual prepay. All doses priced the same.)
Pricing model
Flat — dose increases don't raise the monthly price
What's included
Consult · Medication · Shipping
Availability
All 50 states
FDA status
No FDA warning letter on record

How Curve scores

Six columns, each one computed from something Curve has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.

Value25%

6.2/10

$225/month is 16% below the register median of $267 for compounded tirzepatide.

Effectiveness25%

10.0/10

Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).

User Experience15%

5.0/10

Where this seller first shows a price is not recorded yet, so the signup is unscored and sits at the midpoint.

Trust & Safety15%

7.5/10

names its dispensing pharmacy; withholds price until after the intake; publishes its state list. Our verification confidence is high.

Accessibility10%

10.0/10

Publishes coverage in 50 of 50 states.

Support10%

7.0/10

The price covers medication, consult, shipping.

6weighted dimensions
560sellers in the register
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →

What we checked on Curve

Last checked August 2026
  • Re-read the price on file across 2 dose or plan tiers
  • Checked state coverage: all 50
  • Established what the monthly figure covers, and what it leaves out
  • Confirmed which compounding pharmacy fills the order, and its accreditation
  • Searched our FDA enforcement register for this operator

Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: high.

GLP-1 medications Curve offers

Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.

SemaglutideTirzepatideWegovyOzempicMounjaroZepboundRybelsus

Pricing

Prices re-verified

MonthlyCompounded
$175/mo
semaglutide

Month-to-month; drops to $145/mo (quarterly), $120/mo (6-month), or $99/mo on annual prepay. All doses priced the same.

MonthlyCompounded
$225/mo
tirzepatide

Month-to-month; drops to $199/mo (quarterly), $175/mo (6-month), or $135/mo on annual prepay. All doses priced the same.

Check the price yourself before you pay

Every figure here was read off Curve's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.

See Curve pricing →

Curve compounding-pharmacy partners

Each partner below is a 503A or 503B pharmacy that Curve routes prescriptions through. Each entry is anchored to a verbatim primary-source quote from the provider’s or pharmacy’s own site.

VialsRx

  • 503A
“We partner with a trusted, US-based compounding pharmacy — VialsRx — that operate in full compliance with FDA guidelines and USP 797 sterile compounding standards.”

Source: trycurve.co · Verified 2026-07-20

Compare every compounding pharmacy we’ve reviewed →

In its favor

  • Semaglutide at $175 a month, within the normal band around this register's $189 median for the same drug and form
  • The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
  • The monthly figure covers medication, consult, shipping
  • Coverage is published for all 50 states
  • Names VialsRx as the dispensing pharmacy, which most sellers in this register do not do
  • No FDA warning letter matched this operator when we searched our enforcement register

Against it

  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

What Curve charges

The standing price at Curve is $175/month, unchanged as the dose goes up. Flat dose pricing matters more than it reads: on a tiered plan the bill grows as the dose does, which means the figure that persuaded you to sign up is not the figure you end up living with.

  • Compounded semaglutide — $175/month
  • Compounded tirzepatide — $225/month

The median across the GLP-1 providers we track is about $169/month, so this lands mid-market — close enough that the deciding factor is unlikely to be price.

Found dispenses semaglutide and tirzepatide from $149/month, which makes it the honest comparison to run before committing here.

What Curve dispenses

Curve prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. These are compounded preparations from a licensed pharmacy rather than approved pens, which is where the lower price comes from. A compounded drug is not FDA-approved as a finished product — the specific preparation has not been reviewed for safety, efficacy or manufacturing quality.

What we could verify

On the record: it treats patients in all 50 states, it dispenses through an accredited compounding pharmacy, and it names the pharmacy that fills its prescriptions. We searched the federal warning-letter record for this operator and came back with nothing. Because the medication is compounded, the named pharmacy is the detail that matters most here — it is the license you can actually look up. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.

Who should look elsewhere

  • You want the FDA-approved pen specifically. Nothing here is the approved finished product.
  • You need to bill insurance. Like most of this market, this is cash-pay.

It fits if

  • you want the price to stop moving as your dose climbs
  • you need access regardless of where you live

Our read

Curve lands mid-market on price without a standout advantage or an obvious problem. It comes down to whether its particular package fits. Breeze Meds is the nearest comparison we track, and worth reading alongside this.

The Bottom Line

Curve's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.

Score: 7.6/10Best for: knowing which pharmacy fills the vial — it names VialsRxFrom: $175/mo

Before you pay Curve

Starting at $175/month. Check today's price, then book the free consultation.

Visit Curve →

Where Curve is the wrong choice

No seller in this register suits every reader, and saying otherwise would be the easiest way to sell one. On these four counts another entry does better.

  • If you need the FDA-approved pen rather than a compounded vial, consider Found.
  • If the standing monthly cost is what decides it, consider Telos Rx (from $99/mo).
  • If you want a human checking in, not just a prescription, consider Oak.
See all alternatives to Curve →

Frequently Asked Questions

Glossary

The words sellers use, defined. Tap any term.

Sources

Cited across this Curve review: primary regulatory filings, and peer-reviewed studies.

Sources & methodology — as of August 2026
  1. 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See Curve's current pricing

Plans start at $175/month. The free consultation is where you learn whether you qualify, and what it costs today.

Visit Curve →